Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract,published online September 2014. DOI: 10.1177/1078155214551315
Restricted accessEditorialFirst published online August, 2015
Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract,published online September 2014. DOI: 10.1177/1078155214551315
Bicakli DH, Varol U, Degirmenci M, et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract 2014. DOI: 10.1177/1078155214551315.
2.
Myron JohnsonAMerliniGSheldonJ. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med2007; 45: 419–426.
3.
NiMWeiWFengQ. Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis. Clin Exp Rheumatol2013; 31: 394–399.
4.
OppenheimerJHWenerSCMartinezM. Effect of prednisone on thyroxine-binding proteins. J Clin Endocrinol Metabol1966; 26: 715–721.
5.
Le MoullacBGouachePBleiberg-DanielF. Regulation of hepatic transthyretin messenger RNA levels during moderate protein and food restriction in rats. J Nutr1992; 122: 864–870.
6.
GharekhaniAKhatamiMRDashti-KhavidakiS. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J Ren Nutr2014; 24: 177–185.
7.
BruguerolleBBouvenotGArnaudC. [Circadian rhythms of the so-called inflammation proteins in healthy subjects]. Rev Rhum Mal Osteoartic1986; 53: 313–316.
